Barrier Film Platform
Explores puncture resistance, seal behavior, peel force, and sterile barrier confidence for pouch families.
The Fujifilm Innovation Lab connects barrier materials, packaging validation, digital traceability, and clinician feedback into a practical pipeline for commercial medical device buyers.
Innovation at Fujifilm is measured by whether a product can pass clinical, operational, and procurement scrutiny. A new glove material must feel usable at the bedside, support barrier expectations, and remain traceable through distribution. A pouch substrate must protect instruments, peel consistently, and make indicator interpretation easy under shift pressure. A wipe system must pair chemistry with workflow training so contact time survives the real world.
The lab studies these questions through controlled testing and then translates results into documents buyers can use: comparison matrices, IFU updates, quality summaries, packaging rationale, and pilot plans.
Explores puncture resistance, seal behavior, peel force, and sterile barrier confidence for pouch families.
Studies glove donning, cuff security, tactile feel, and skin-contact response across procedure durations.
Reviews disinfectant wipe substrate, wetness retention, surface interaction, and contact-time education.
Connects UDI, carton hierarchy, lot records, and recall workflows to procurement and distributor systems.
The Innovation Lab is intentionally close to implementation. Many medical consumables look simple until they are placed in a hospital with mixed departments, multiple shifts, limited storage, and strict approval paths. Fujifilm's process begins with a clear intended use and a risk question. What clinical problem is this material or package solving? Which standard, test method, or validation record should support the claim? Which department will feel the change first? How will a distributor represent the item in its catalog? By answering those questions early, the lab prevents promising ideas from becoming confusing product conversions. This approach also helps customers evaluate emerging products without relying on hype. They can review the evidence, pilot the product in a controlled setting, and decide whether the innovation belongs in the formulary.
We can review barrier goals, packaging pain points, traceability gaps, or conversion risks before your next sourcing event.
Start lab review